Yellow Fever and Rabies: Investigational Vaccines

We are testing two new vaccines for yellow fever and rabies in healthy adults aged 18 to 40. The study aims to evaluate their safety and how well they trigger an immune response.

Safety phase (I)Infectious Diseases

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Universitair Ziekenhuis Gent
Center for Vaccinology (CEVAC)
Ledeberg, Belgium
University Of Antwerp
Centre for Evaluation of Vaccination (CEV)
Wilrijk, Belgium
Sponsor: AstriVax
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.